HeartLung AI-CVD® Investigator Dr. Reza Mirjalili Wins SCCT 2026 Rapid-Fire Award for AI-CVD® Heart Failure Prediction

Award-winning presentation recognizes AI-CVD-HF heart failure prediction model leveraging coronary artery calcium (CAC) scans HONG KONG, January 27, 2026 /EINPresswire.com/ — HeartLung AI announced ...
Scientific Research Publishing

Guillain-Barré Syndrome Presenting as Pseudo-Cerebellar Syndrome: A Case Report from a Resource-Limited Setting in Sub-Saharan Africa ()

Guillain-Barré Syndrome Presenting as Pseudo-Cerebellar Syndrome: A Case Report from a Resource-Limited Setting in Sub-Saharan Africa Guillain-Barré Syndrome (GBS) is the most frequent cause of acute ...

Zenocutuzumab--zbco Receives FDA Orphan Drug Designation for Treatment of Cholangiocarcinoma

Zenocutuzumab--zbco, marketed as BIZENGRI (R), received Breakthrough Therapy Designation from the FDA in October 2025 and was granted accelerated approval in December 2024 for adults with advanced ...
TMCnet

Nature Medicine Publishes Results from the Pivotal DEVOTE Study of High-Dose Regimen of Nusinersen in Spinal Muscular Atrophy

The high-dose regimen of SPINRAZA (nusinersen) is approved in the European Union and Japan. The high-dose regimen is under review with the United States Food and Drug Administration (FDA) and has a ...
The Lancet

Burden of respiratory tract cancers in China and its provinces, 1990–2021: a systematic analysis of the Global Burden of Disease Study 2021

gClinical Research Design Division, Clinical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, 510120, China hDepartment of Ophthalmology, Wuhan Wuchang ...